Skill Guide

Genomics and molecular biology fundamentals (central dogma, gene regulation, variant types)

The core body of knowledge encompassing the flow of genetic information from DNA to RNA to protein (central dogma), the mechanisms controlling gene expression, and the classification and functional impact of DNA sequence variations.

This skill is foundational for roles in biotechnology, pharmaceutical R&D, and clinical diagnostics, directly enabling the development of targeted therapeutics, diagnostic assays, and genetically informed patient care. Understanding these fundamentals is non-negotiable for accurately interpreting biological data and driving innovation in personalized medicine and synthetic biology.

1 Careers

1 Categories

9.2 Avg Demand

15% Avg AI Risk

How to Learn Genomics and molecular biology fundamentals (central dogma, gene regulation, variant types)

Focus on memorizing and diagramming the central dogma (DNA replication, transcription, translation). Learn the one-letter amino acid code and standard genetic code table. Differentiate between major variant types: Single Nucleotide Variants (SNVs), insertions/deletions (indels), and copy number variations (CNVs).

Apply knowledge by annotating a simple gene sequence with variant calls (e.g., using ClinVar). Analyze a case study of a disease-causing variant (e.g., sickle cell anemia's Glu6Val) to trace its molecular consequence through the central dogma. Common mistake: Confusing synonymous variants with 'no impact' without considering splicing or codon usage bias.

Synthesize knowledge to evaluate complex gene regulatory networks (e.g., feedback loops in the p53 pathway) and their disruption by non-coding variants. Assess the combined effect of multiple variants (oligogenic inheritance) on a phenotype. Master the interpretation of structural variants and their role in complex diseases.

Practice Projects

Beginner

Project

Variant Annotation and Classification Report

Scenario

You are provided with a list of 5 raw variant calls (e.g., chr17:7674220 C>T) from a gene panel sequencing run. Your task is to produce a standardized annotation and classification report for each.

How to Execute

1. Use the UCSC Genome Browser or Ensembl to map each variant to its gene and exon. 2. Use the Variant Effect Predictor (VEP) or ANNOVAR to predict the molecular consequence (e.g., missense, nonsense, synonymous). 3. Cross-reference each variant in ClinVar and gnomAD to determine its clinical significance and population frequency. 4. Compile a report classifying each variant per ACMG guidelines (Pathogenic, Likely Pathogenic, VUS, Likely Benign, Benign).

Intermediate

Case Study/Exercise

Gene Regulation Mechanism Dissection

Scenario

A patient has a variant in the *intronic* region of the *LMNA* gene associated with dilated cardiomyopathy. The variant does not alter the protein sequence. Your task is to hypothesize its regulatory mechanism.

How to Execute

1. Identify if the variant falls within a known enhancer or silencer element using ENCODE data. 2. Check if it disrupts a predicted transcription factor binding motif (e.g., using JASPAR). 3. Evaluate if it creates or disrupts an alternative splice site using tools like MaxEntScan. 4. Formulate a testable hypothesis (e.g., 'The variant disrupts an enhancer, reducing LMNA expression in cardiac tissue') and propose a validation experiment (e.g., luciferase assay, RT-qPCR).

Advanced

Project

Multi-Omic Data Integration for Variant Prioritization

Scenario

You are analyzing whole-genome sequencing data from a cohort of patients with an idiopathic neurological disorder. Several non-coding variants of unknown significance are identified near a candidate gene. Your goal is to prioritize one for functional studies.

How to Execute

1. Use chromatin interaction data (Hi-C, Capture-C) to determine which variants physically interact with the candidate gene's promoter. 2. Overlay tissue-specific epigenetic marks (e.g., H3K27ac for active enhancers) from public databases like Roadmap Epigenomics. 3. Analyze RNA-seq data from the cohort to correlate the variant's genotype with candidate gene expression (eQTL analysis). 4. Synthesize all lines of evidence into a prioritization score to select the top candidate variant for CRISPR-based editing in a cellular model.

Tools & Frameworks

Bioinformatics Software & Databases

Variant Effect Predictor (VEP)ClinVargnomADUCSC Genome BrowserANNOVAR

VEP and ANNOVAR are primary tools for annotating the genomic and functional consequences of variants. ClinVar is the definitive database for clinical significance assertions. gnomAD provides critical population allele frequency data to assess rarity. The UCSC Genome Browser is the essential platform for visualizing variants in their genomic context.

Interpretation Frameworks & Guidelines

ACMG/AMP Variant Classification GuidelinesHuman Genome Variation Society (HGVS) Nomenclature

ACMG/AMP provides the standardized, evidence-based framework for classifying variants from Benign to Pathogenic, mandatory for clinical reporting. HGVS nomenclature is the required language for unambiguously describing variants in reports and publications.

Interview Questions

Answer Strategy

Use a structured, evidence-based approach following the ACMG framework. The candidate should outline evaluating: 1) Computational/Predictive data (REVEL, CADD scores), 2) Functional data from literature, 3) Segregation data in the family, 4) The variant's location in a known functional domain (e.g., DNA-binding domain). A strong answer avoids definitive claims without data and emphasizes accumulating evidence.

Answer Strategy

The interviewer is testing the candidate's depth beyond the basic central dogma. The answer must demonstrate knowledge of mRNA processing and regulation. A top response would detail: 1) Disruption of an exonic splicing enhancer (ESE) or silencer (ESS) leading to exon skipping, and 2) Alteration of codon usage affecting translational speed and protein folding, citing a known example like the synonymous CFTR variant c.1679G>A (p.Arg560=) which causes aberrant splicing.